THE JOHNS HOPKINS UNIV SCHOOL OF MEDICINE has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KAOHSIUNG CHANG GUNG MEMORIAL HOSPITAL, CHI MEI FOUNDATION HOSPITAL and KIDO HIROSHI.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 16 | |
#2 | United States | 2 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Measuring microorganism processes | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Foods | |
#7 | Diagnosis and surgery | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kuhajda Francis P | 5 |
#2 | Lee Se-Jin | 4 |
#3 | Ronnett Gabriele | 3 |
#4 | Townsend Craig A | 3 |
#5 | Phakdeekitcharoen Bunyong | 3 |
#6 | Watnick Terry J | 3 |
#7 | Mcpherron Alexandra C | 3 |
#8 | Germino Gregory G | 3 |
#9 | Adler Adam | 2 |
#10 | Thupari Jagan N | 2 |
Publication | Filing date | Title |
---|---|---|
AU2008201147A1 | Melanoma cell lines expressing shared melanoma antigens and methods of using same | |
AU2006209266A1 | Promyostatin peptides and methods of using same | |
AU2006202320A1 | Weight loss induced by reduction in neuropeptide Y level | |
AU2006201079A1 | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species | |
AU2005202456A1 | Compositions and methods for restoring a normal pattern of imprinting to cells | |
AU2003262440A1 | Growth differentiation factor-11 |